Carrier-linked treprostinil prodrugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9561287
APP PUB NO 20140296150A1
SERIAL NO

14238437

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to prodrugs or a pharmaceutically acceptable salt thereof comprising a covalent treprostinil carrier conjugate as well as pharmaceutical composition comprising said compounds. The compounds may be used as medicaments, especially for diseases or disorders which can be treated by treprostinil, such as pulmonary arterial hypertension (PAH).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASCENDIS PHARMA A/S2900 HELLERUP

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bisek, Nicola Heidelberg, DE 25 57
Hersel, Ulrich Heidelberg, DE 72 1020
Keil, Oliver Heidelberg, DE 32 228
Lessmann, Torben Neustadt an der Weinstrasse, DE 13 96
Maitro, Guillaume Mannheim, DE 21 114
Rau, Harald Dossenheim, DE 112 1733
Sprogøe, Kennett Holte, DK 62 347
Wegge, Thomas Heidelberg, DE 59 821
Zettler, Joachim Heidelberg, DE 23 113

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00